Collaborative multidisciplinary workshop report: Clinical antimicrobial trials for primary and secondary prevention of atherosclerotic cardiovascular disease

Journal of Infectious Diseases

Volumn 181, Issue 6 SUPPL. 3, 2000, Pages

  Rosen, Henry ^a   Muhlestein, Joseph B ^e,m   Bartlett, John ^f   Chen, Shaw ^g   Chikami, Gary ^h   Corson, Marshall ^b   Shah, P K ⁱ   Gurfinkel, Enrique ^k   Handsfield, Hunter ^c,d   Jackson, Lisa ^c   Knirsch, Charles ^l   Kronmal, Richard ^a   McCutchan, J Allen ^j   Shea, Steven ^l  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Public Health Seattle King County   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g Division of Cardio Renal Drugs   (United States)

^h HFD 520   (United States)

ⁱ CEDARS SINAI MEDICAL CENTER   (United States)

^j UNIVERSITY OF SAN DIEGO   (United States)

^k HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^l Och Spine at New York Presbyterian Hospitals   (United States)

^m LDS HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL THERAPY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHLAMYDOPHILA PNEUMONIAE; CONFERENCE PAPER; CORONARY ARTERY DISEASE; HEART INFARCTION; MEDICAL RESEARCH; PRIMARY PREVENTION; PRIORITY JOURNAL; SECONDARY PREVENTION;

EID: 0034095888     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315597     Document Type: Conference Paper

References (4)

1. 1. Gupta S, Leatham F.W. Carrington D, Mendall MA, Kaski JC. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997;96:404-7.
2. 2. Gurfinkel E, Bozovich G, Daroca A. Beck E, Mautner B. Randomized trial of roxithromycin in non Q-wave coronary syndromes: ROXIS pilot study. ROXIS Study Group. Lancet 1997; 350:404-7.
3. 3. Anderson JL, Muhlestein JB, Carlquist J, et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection. The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study. Circulation 1999;99:1540-7.
4. 4. Labro MT. Anti-inflammatory activity of macrolides: a new therapeutic potential? J Antimicrob Chemother 1998;41(suppl B):37-46.